Entity
  • Standard BioTools

    Created in 1999
  • BETA

    Trend leader (A+)
    Existing signals make this entity one of the most dynamic startups
  • Social networks

    7,021 7,009 32,961
  • Activities

  • Technologies

  • Entity types

  • Location

    2 Tower Pl Suite 2000, South San Francisco, CA 94080, USA

    South San Francisco

    United States of America

  • Employees

    Scale: 501-1000

    Estimated: 946

  • Engaged corporates

    8
    1 8
  • Added in Motherbase

    3 years, 5 months ago
Description
  • Value proposition

    Providing essential, standardized tools to accelerate breakthroughs in human health
    Microfluidics | Cytometry | Imaging

    Standard BioTools delivers the leading proteomic and multi-omic solutions that enable researchers to discover unique biological insights not accessible by other technologies.

    Mass Cytometry, Tissue Imaging, NGS Library Prep, Genotyping, Gene Expression, Copy Number Variation, Real-Time PCR, and Single-Cell Genomics

  • Standard BioTools | Standard BioTools

    We support the scientific community in the quest to solve unanswered challenges in health and disease across basic, translational and clinical research, including the fields of cancer, inflammatory diseases, immunotherapies and environmental monitoring. Harnessing the power of proprietary CyTOF® and microfluidics technologies, Fluidigm products provide comprehensive cell analysis aimed to elevate scientific data into actionable insights.

  • https://www.standardbio.com/
Corporate interactions BETA
Corporate TypeTweets Articles
J.P. Morgan J.P. Morgan
Bank
Other

9 Jan 2025


Illumina
Illumina
Biotechnology, Biotechnology Research
Illumina
Biotechnology, Biotechnology Research
Other

13 Jan 2025


Novartis
Novartis
Pharmaceutical, Pharmaceutical Manufacturing
Novartis
Pharmaceutical, Pharmaceutical Manufacturing
Not capitalistic
Not partnership
Event

18 Apr 2016


AstraZeneca
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing
Other

9 May 2021


European Bioinformatics Institute | EMBL-EBI
European Bioinformatics Institute | EMBL-EBI
Research, Software Development
European Bioinformatics Institute | EMBL-EBI
Research, Software Development
Not capitalistic
Not partnership
Event

25 May 2016


Illumina For Startups
Illumina For Startups
Startup accelerator & VC, Biotechnology, Biotechnology Research
Illumina For Startups
Startup accelerator & VC, Biotechnology, Biotechnology Research
Other

26 May 2020


Genopole
Genopole
Biotechnology, Biotechnology Research
Genopole
Biotechnology, Biotechnology Research
Not capitalistic
Not partnership
Event

5 May 2019


Nasdaq
Nasdaq
Finance, Financial Services
Nasdaq
Finance, Financial Services
Other

20 Apr 2022


Similar entities
AxisEntities
No similarities
Standard BioTools
1 month ago 81 2

Proteomics is entering a transformative era, and we are excited to be collaborating with Illumina and pharma leaders on a new proteomics pilot program with the UK Biobank. The new Illumina Protein Prep NGS-based proteomics platform, powered by our SOMAmerTM technology, will provide deeper biological insights into this cohort. We look forward to sharing the data from this project with the research community later this year.

Read more about this collaboration at: https://lnkd.in/eFuum3ed

Learn about our work with biobanks around the world: https://lnkd.in/ejvBW5RV
#Proteomics #Illumina

Standard BioTools
1 month, 1 week ago 14

Join us on January 30, at 2 PM JST to explore the latest advancements in understanding and managing immune-related adverse events (irAE) caused by immune checkpoint inhibitors (ICI).

In this webinar, hear from leading experts from the Graduate School of Medicine, Kyoto University:

Dr. Kosaku Murakami will share the results of his research using #multimodality analysis, including mass cytometry.

Dr. Shinobu Suzuki will introduce "Seeds-Hub," which highlights insights from CyTOFTM technology.

🔗 Register now to learn more: https://bit.ly/41DG2kW

#Webinar #CancerImmunotherapy #ClinicalImmunology #CyTOF #ImmuneCheckpointTherapy

Standard BioTools
1 month, 1 week ago 62

Michael Egholm, President and CEO of Standard BioTools, will share a corporate presentation on January 16 at 9:45am PT at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco.

A live audio webcast will be available to investors and other interested parties on our Investor Relations page at Events & Presentations.

Standard BioTools
1 month, 1 week ago 29

Tomorrow at the 2nd Annual T Cells in the Brain Symposium in New York, we have two very exciting poster presentations about #IMC and its use in #Neurodegeneration research.

Between 4:00 pm - 5:30 pm, James Pemberton and Nick Zabinyakov will be presenting:

❇️ "Deciphering Spatial Cellular Heterogeneity in Neurodegenerative Brain Pathology With Imaging Mass Cytometry."
Explore how whole slide imaging modes and single-cell analysis unravel the complex cellular composition of the neurodegenerative brain.

❇️ "Revealing the Heterogeneity of Glioblastoma Using High-Plex Imaging Mass Cytometry With Whole Slide Imaging Modes."
Learn how this research takes us closer to advanced diagnostic and therapeutic options for cancer stem cell differentiation.

If you’re in attendance, connect with us at the symposium!

Learn more about high-plex imaging in neurodegeneration research: https://lnkd.in/eUtE2-xX
#TCB2025 #Immunology

Standard BioTools
1 month, 1 week ago 25

New year, new webinar! 👀

On January 22, join us for "Bridging the Gap: Insights from Mouse and Human Models in Pancreatic Cancer Research" featuring guest speaker Marco Erreni, PhD from Humanitas Research Hospital.

Register now! https://lnkd.in/esUcZK_V
08:00 PT | 11:00 ET | 16:00 GMT | 17:00 CET

You will learn:
✅ How Imaging Mass CytometryTM (IMCTM) helps assess cell abundance, distribution, and phenotypes in PDAC progression across murine models.
✅ The use of IMC to analyze 8 human PDAC tissues, uncovering insights into cancer-associated fibroblast clusters and molecular pathways.
✅ How integrating mouse and human model analyses provides a comprehensive understanding of tumor-immune-stroma interactions to shape future therapies.

#CancerResearch #Cytometry #IMC #Imaging

Social network dynamics